Immatics and MD Anderson announce launch of Immatics US, Inc., to...
Company to be based in Houston with first round funding of $60 million
MD Anderson News Release 08/26/2015
Immatics Biotechnologies...
Internationally recognized leader to direct Moon Shots...
MD Anderson News Release 08/26/2015
The University of Texas MD Anderson Cancer Center has appointed former U.S. Public Health...
MD Anderson to host evening fun run supporting skin cancer...
MD Anderson News Release 08/26/2015
Runners and walkers will soon hit the streets for the eighth annual AIM for the CURE Melanoma...
Generic heart medication shown to prolong ovarian cancer patients’...
Even despite prognostic factors and co-morbidities associated with poorer outcomes
MD Anderson News Release 08/23/2015
In a...
UTMB, MD Anderson to collaborate on League City campus
MD Anderson News Release 08/20/2015
The University of Texas Medical Branch at Galveston and The University of Texas MD Anderson...
MD Anderson to build new outpatient center in West Houston
MD Anderson News Release 08/20/2015
With the approval of The University of Texas System Board of Regents today, The University of...
MD Anderson study reveals new insight into tumor progression
Regulation of tumor ‘microenvironment’ may offer alternate approach for treatment
MD Anderson News Release 08/17/2015
Merck and MD Anderson announce immuno-oncology research...
Clinical trials to evaluate Merck’s KEYTRUDA® (pembrolizumab) in combination with other medicines and treatments across multiple tumor...
Helping preschoolers deploy ‘superpowers’ against sunburn
Ray and the Sunbeatables™ debut through CATCH; arise from MD Anderson research
MD Anderson News Release 08/12/2015
Five...
MD Anderson names Valerae O. Lewis, M.D., chair of...
Dr. Lewis is internationally recognized for her expertise in pelvic sarcoma surgery and substantial contributions in shaping...
Poor survival among colorectal cancer patients tied to...
MD Anderson News Release 08/10/2015
A protein called CSN6 has been found to be correlated with poor survival among patients...
Shorter course of radiation therapy associated with less...
MD Anderson researchers recommend hypofractionated treatment as a starting point for treatment discussion between patients,...
Potential new therapy approaches to reverse kidney damage...
Study shows that cell plasticity program resulting from kidney damage can be targeted to reverse disease and fibrosis.
MD Anderson...
MD Anderson study reveals new insight into DNA Repair
The enzyme fumarase key to reversing genetic damage leading to cancer and therapy resistance
MD Anderson News Release 08/03/2015<...